These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20879650)

  • 21. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune evasion in human papillomavirus-associated cervical cancer.
    Tindle RW
    Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV-induced oropharyngeal cancer, immune response and response to therapy.
    Vu HL; Sikora AG; Fu S; Kao J
    Cancer Lett; 2010 Feb; 288(2):149-55. PubMed ID: 19628331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.
    Ashrafi GH; Brown DR; Fife KH; Campo MS
    Virus Res; 2006 Sep; 120(1-2):208-11. PubMed ID: 16780984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV: from infection to cancer.
    Stanley MA; Pett MR; Coleman N
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiology of HPV and HPV vaccines.
    Stanley M
    Gynecol Oncol; 2008 May; 109(2 Suppl):S15-21. PubMed ID: 18474288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinocellular carcinoma from warts in a HPV infection natural history lasting 49 years. Virus strategy or host choice? Implications for researches and therapeutic vaccines.
    Criscione SM
    Med Hypotheses; 2011 Nov; 77(5):777-81. PubMed ID: 21840649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clearance, persistence and recurrence of HPV infection].
    Denis F; Hanz S; Alain S
    Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evasion of host immune defenses by human papillomavirus.
    Westrich JA; Warren CJ; Pyeon D
    Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of inflammation in HPV carcinogenesis.
    Boccardo E; Lepique AP; Villa LL
    Carcinogenesis; 2010 Nov; 31(11):1905-12. PubMed ID: 20819779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Defensive Mechanisms against Human Papillomavirus Infection.
    Moerman-Herzog A; Nakagawa M
    Clin Vaccine Immunol; 2015 Aug; 22(8):850-7. PubMed ID: 26063238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunology of genital human papilloma virus infection.
    Stanley M
    Eur J Dermatol; 1998; 8(7 Suppl):8-12; discussion 20-2. PubMed ID: 10387957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue effects of and host response to human papillomavirus infection.
    Jenson AB; Kurman RJ; Lancaster WD
    Dermatol Clin; 1991 Apr; 9(2):203-9. PubMed ID: 1647900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitination in host immune response to human papillomavirus infection.
    Zhou Q; Zhu K; Cheng H
    Arch Dermatol Res; 2011 May; 303(4):217-30. PubMed ID: 21400034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
    Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.